268 related articles for article (PubMed ID: 34355696)
1. Expanding the MECP2 network using comparative genomics reveals potential therapeutic targets for Rett syndrome.
Unterman I; Bloch I; Cazacu S; Kazimirsky G; Ben-Zeev B; Berman BP; Brodie C; Tabach Y
Elife; 2021 Aug; 10():. PubMed ID: 34355696
[TBL] [Abstract][Full Text] [Related]
2. Proteomic and transcriptional changes associated with MeCP2 dysfunction reveal nodes for therapeutic intervention in Rett syndrome.
Marballi K; MacDonald JL
Neurochem Int; 2021 Sep; 148():105076. PubMed ID: 34048843
[TBL] [Abstract][Full Text] [Related]
3. Deciphering Rett syndrome with mouse genetics, epigenomics, and human neurons.
Tao J; Wu H; Sun YE
Int Rev Neurobiol; 2009; 89():147-60. PubMed ID: 19900619
[TBL] [Abstract][Full Text] [Related]
4. Rett syndrome and MeCP2.
Liyanage VR; Rastegar M
Neuromolecular Med; 2014 Jun; 16(2):231-64. PubMed ID: 24615633
[TBL] [Abstract][Full Text] [Related]
5. Profiling beneficial and potential adverse effects of MeCP2 overexpression in a hypomorphic Rett syndrome mouse model.
Vermudez SAD; Gogliotti RG; Arthur B; Buch A; Morales C; Moxley Y; Rajpal H; Conn PJ; Niswender CM
Genes Brain Behav; 2022 Jan; 21(1):e12752. PubMed ID: 34002468
[TBL] [Abstract][Full Text] [Related]
6. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.
Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J
Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047
[TBL] [Abstract][Full Text] [Related]
7. Multiplex epigenome editing of
Qian J; Guan X; Xie B; Xu C; Niu J; Tang X; Li CH; Colecraft HM; Jaenisch R; Liu XS
Sci Transl Med; 2023 Jan; 15(679):eadd4666. PubMed ID: 36652535
[TBL] [Abstract][Full Text] [Related]
8. MeCP2 and Rett syndrome: reversibility and potential avenues for therapy.
Gadalla KK; Bailey ME; Cobb SR
Biochem J; 2011 Oct; 439(1):1-14. PubMed ID: 21916843
[TBL] [Abstract][Full Text] [Related]
9. Severe offtarget effects following intravenous delivery of AAV9-MECP2 in a female mouse model of Rett syndrome.
Matagne V; Borloz E; Ehinger Y; Saidi L; Villard L; Roux JC
Neurobiol Dis; 2021 Feb; 149():105235. PubMed ID: 33383186
[TBL] [Abstract][Full Text] [Related]
10. Rett syndrome: the complex nature of a monogenic disease.
Renieri A; Meloni I; Longo I; Ariani F; Mari F; Pescucci C; Cambi F
J Mol Med (Berl); 2003 Jun; 81(6):346-54. PubMed ID: 12750821
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D Supplementation Rescues Aberrant NF-κB Pathway Activation and Partially Ameliorates Rett Syndrome Phenotypes in
Ribeiro MC; Moore SM; Kishi N; Macklis JD; MacDonald JL
eNeuro; 2020; 7(3):. PubMed ID: 32393583
[TBL] [Abstract][Full Text] [Related]
12. Role of DNA Methyl-CpG-Binding Protein MeCP2 in Rett Syndrome Pathobiology and Mechanism of Disease.
Pejhan S; Rastegar M
Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33429932
[TBL] [Abstract][Full Text] [Related]
13. Two new Rett syndrome families and review of the literature: expanding the knowledge of MECP2 frameshift mutations.
Ravn K; Roende G; Duno M; Fuglsang K; Eiklid KL; Tümer Z; Nielsen JB; Skjeldal OH
Orphanet J Rare Dis; 2011 Aug; 6():58. PubMed ID: 21878110
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D modulates cortical transcriptome and behavioral phenotypes in an Mecp2 heterozygous Rett syndrome mouse model.
Ribeiro MC; MacDonald JL
Neurobiol Dis; 2022 Apr; 165():105636. PubMed ID: 35091041
[TBL] [Abstract][Full Text] [Related]
15. Graded and pan-neural disease phenotypes of Rett Syndrome linked with dosage of functional MeCP2.
Chen X; Han X; Blanchi B; Guan W; Ge W; Yu YC; Sun YE
Protein Cell; 2021 Aug; 12(8):639-652. PubMed ID: 32851591
[TBL] [Abstract][Full Text] [Related]
16. Recent endeavors in MECP2 gene transfer for gene therapy of Rett syndrome.
Sinnett SE; Gray SJ
Discov Med; 2017 Oct; 24(132):153-159. PubMed ID: 29272692
[TBL] [Abstract][Full Text] [Related]
17. Identification of molecular signatures and pathways involved in Rett syndrome using a multi-omics approach.
Pascual-Alonso A; Xiol C; Smirnov D; Kopajtich R; Prokisch H; Armstrong J
Hum Genomics; 2023 Sep; 17(1):85. PubMed ID: 37710353
[TBL] [Abstract][Full Text] [Related]
18. Radically truncated MeCP2 rescues Rett syndrome-like neurological defects.
Tillotson R; Selfridge J; Koerner MV; Gadalla KKE; Guy J; De Sousa D; Hector RD; Cobb SR; Bird A
Nature; 2017 Oct; 550(7676):398-401. PubMed ID: 29019980
[TBL] [Abstract][Full Text] [Related]
19. Cell cloning-based transcriptome analysis in Rett patients: relevance to the pathogenesis of Rett syndrome of new human MeCP2 target genes.
Nectoux J; Fichou Y; Rosas-Vargas H; Cagnard N; Bahi-Buisson N; Nusbaum P; Letourneur F; Chelly J; Bienvenu T
J Cell Mol Med; 2010 Jul; 14(7):1962-74. PubMed ID: 20569274
[TBL] [Abstract][Full Text] [Related]
20. Rett syndrome and the urge of novel approaches to study MeCP2 functions and mechanisms of action.
Bedogni F; Rossi RL; Galli F; Cobolli Gigli C; Gandaglia A; Kilstrup-Nielsen C; Landsberger N
Neurosci Biobehav Rev; 2014 Oct; 46 Pt 2():187-201. PubMed ID: 24594195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
